216 related articles for article (PubMed ID: 32495883)
1. SNHG3 silencing suppresses the malignant development of triple-negative breast cancer cells by regulating miRNA-326/integrin α5 axis and inactivating Vav2/Rac1 signaling pathway.
Wang P; Liu GZ; Wang JF; Du YY
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5481-5492. PubMed ID: 32495883
[TBL] [Abstract][Full Text] [Related]
2. Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway.
Xiao Y; Li Y; Tao H; Humphries B; Li A; Jiang Y; Yang C; Luo R; Wang Z
Cancer Lett; 2018 Oct; 433():199-209. PubMed ID: 29964204
[TBL] [Abstract][Full Text] [Related]
3. Deletion of
Meng Q; Wang L; Lv Y; Wu J; Shi W
Cancer Biother Radiopharm; 2021 Feb; 36(1):23-35. PubMed ID: 32319789
[No Abstract] [Full Text] [Related]
4. Long non-coding RNA SNHG3 promotes breast cancer cell proliferation and metastasis by binding to microRNA-154-3p and activating the notch signaling pathway.
Jiang H; Li X; Wang W; Dong H
BMC Cancer; 2020 Sep; 20(1):838. PubMed ID: 32883233
[TBL] [Abstract][Full Text] [Related]
5. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X
Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG3 regulates laryngeal carcinoma proliferation and migration by modulating the miR-384/WEE1 axis.
Wang L; Su K; Wu H; Li J; Song D
Life Sci; 2019 Sep; 232():116597. PubMed ID: 31238052
[TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG3 Facilitates the Malignant Phenotype of Cholangiocarcinoma Cells via the miR-3173-5p/ERG Axis.
Sun ZP; Tan ZG; Peng C; Yi WM
J Gastrointest Surg; 2022 Apr; 26(4):802-812. PubMed ID: 34647226
[TBL] [Abstract][Full Text] [Related]
9. The knockdown of SNHG3 inhibits the progression of laryngeal squamous cell carcinoma by miR-340-5p/YAP1 axis and Wnt/β-catenin pathway.
Kang R; Yao DF; Xu GZ; Zhou YH
Neoplasma; 2020 Sep; 67(5):1094-1105. PubMed ID: 32538668
[TBL] [Abstract][Full Text] [Related]
10. MST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer.
Cho CY; Lee KT; Chen WC; Wang CY; Chang YS; Huang HL; Hsu HP; Yen MC; Lai MZ; Lai MD
Oncotarget; 2016 Mar; 7(12):14586-604. PubMed ID: 26910843
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis.
Cheng L; Xing Z; Zhang P; Xu W
Acta Biochim Pol; 2020 Jun; 67(2):229-237. PubMed ID: 32558530
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA SNHG8 enhances triple-negative breast cancer cell proliferation and migration by regulating the miR-335-5p/PYGO2 axis.
Qian J; Lei X; Sun Y; Zheng L; Li J; Zhang S; Zhang L; Li W; Shi J; Jia W; Tang T
Biol Direct; 2021 Aug; 16(1):13. PubMed ID: 34362407
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA SNHG3 promotes glioma tumorigenesis by sponging miR-485-5p to upregulate LMX1B expression.
Guo X; Zheng J; Yu MJ; Piao HZ; Zhao HY
Kaohsiung J Med Sci; 2021 Oct; 37(10):851-862. PubMed ID: 34153159
[TBL] [Abstract][Full Text] [Related]
14. Silencing long non-coding RNA SNHG3 repairs the dysfunction of pulmonary microvascular endothelial barrier by regulating miR-186-5p/Wnt axis.
Wu Y; Li M; Bai J; Ma X
Biochem Biophys Res Commun; 2023 Jan; 639():36-45. PubMed ID: 36463759
[TBL] [Abstract][Full Text] [Related]
15. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
[TBL] [Abstract][Full Text] [Related]
16. USP6NL mediated by LINC00689/miR-142-3p promotes the development of triple-negative breast cancer.
Ma T; Liu H; Liu Y; Liu T; Wang H; Qiao F; Song L; Zhang L
BMC Cancer; 2020 Oct; 20(1):998. PubMed ID: 33054738
[TBL] [Abstract][Full Text] [Related]
17. TCF3-activated FAM201A enhances cell proliferation and invasion via miR-186-5p/TNKS1BP1 axis in triple-negative breast cancer.
Jia H; Wu D; Zhang Z; Li S
Bioorg Chem; 2020 Nov; 104():104301. PubMed ID: 33011533
[TBL] [Abstract][Full Text] [Related]
18. LINC01096 knockdown inhibits progression of triple-negative breast cancer by increasing miR-3130-3p.
Wang GP; Mou ZL; Xu YY; Liu GX; Wang DM; Zhang HP
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7445-7456. PubMed ID: 31539132
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA SNHG3, induced by IL-6/STAT3 transactivation, promotes stem cell-like properties of gastric cancer cells by regulating the miR-3619-5p/ARL2 axis.
Sun B; Han Y; Cai H; Huang H; Xuan Y
Cell Oncol (Dordr); 2021 Feb; 44(1):179-192. PubMed ID: 32930970
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of long non-coding RNA TP73-AS1 suppresses triple negative breast cancer cell vasculogenic mimicry by targeting miR-490-3p/TWIST1 axis.
Tao W; Sun W; Zhu H; Zhang J
Biochem Biophys Res Commun; 2018 Oct; 504(4):629-634. PubMed ID: 30193732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]